Transplantationstechnologien und Forschung

Transplantation to Treat Retinal Diseases of Clinical Trials Currently Being Conducted with the Use of Adult Stem Cells

Abstract

Rubens c Siqueira*

As a clinical practice, transplantation is a strategy for overcoming disease that could not be readily curable by any existing therapies. The scarcity of the organ number for transplantation in the continuously growing population makes the overall picture critical for meeting the requirement. The prevention of organ rejection, which is caused by the destruction of transplanted tissue by the tissue recipient’s (host) immune system, is mainly focused in routine application. The immunosuppressive drugs provide some benefits against organ rejection, but the immune system with its factors is still a major obstacle in successful transplantation.